This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07528/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07528/identifier/pubchem-compound/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07528/identifier/pubchem-substance/
n9http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB07528/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07528/identifier/chemspider/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07528
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB07528 n14:DB07528
dcterms:title
3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one
adms:identifier
n7:99443999 n10:C52 n11:24812719 n12:22376730 n13:DB07528
n3:IUPAC-Name
n4:271B4D28-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4D2E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4D2D-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4D2A-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4D2B-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4D2C-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4D26-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4D24-363D-11E5-9242-09173F13E4C5 n4:271B4D27-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4D25-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4D34-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4D35-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4D2F-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4D30-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4D32-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4D31-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4D33-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4D3A-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4D3C-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4D3D-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4D39-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4D38-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4D3B-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4D29-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4D36-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4D37-363D-11E5-9242-09173F13E4C5